Precision Medicine: Current Status and Near-Term Implications (Part 2) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, October 12, 2016

Precision Medicine: Current Status and Near-Term Implications (Part 2)



video (7:47 min)

Dr. Haffizulla: Thank you for joining us for this PracticeUpdate. I’m Dr. Farzanna Haffizulla. I am here with Dr. Axel Grothey. Dr. Grothey is a consultant in the Division of Medical Oncology at the Mayo Clinic. He’s also a professor of oncology in clinical and translational science. Again, we’re so happy to have you here today.
Dr. Grothey: Thank you for having me.
Dr. Haffizulla: How are new technologies, such as circulating tumor DNA–based assays, changing the way we consider primary and secondary drug-resistance mechanisms?....

0 comments :

Post a Comment

Your comments?